TRIZEPATIDE AND OTHER GLP1RA AS A NOVEL TREATMENT FOR PATIENTS WITH LIPODYSTROPHY
Application
US20260077019A1
Kind: A1
Mar 19, 2026
Assignee
Rutgers, The State University of New Jersey
Inventors
Christopher Buettner, Svetlana Ten
Abstract
The present disclosure provides methods of treating congenital generalized lipodystrophy using tirzepatide. The disclosure also provides methods for treating a disease in a patient characterized by leptin and leptin signaling deficiency.
CPC Classifications
A61K 38/26
A61K 38/28
A61P 3/00
Filing Date
2025-09-18
Application No.
19332597